The metabolic syndrome and cardiovascular risk in the British Regional Heart Study

International Journal of Obesity

Volumn 32, Issue , 2008, Pages S25-S29

  Wannamethee, S G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cardiovascular disease; Metabolic syndrome; Type 2 diabetes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; AREA UNDER THE CURVE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONFERENCE PAPER; CONFIDENCE INTERVAL; COURSE EVALUATION; DIABETES MELLITUS; DISEASE COURSE; FOLLOW UP; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HEART DEATH; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC METHODS; GREAT BRITAIN; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; STROKE;

ANGINA;

EID: 43449084370     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.32     Document Type: Article

References (34)

1. Expert Panel on Detection, Evaluation and Treatment of High blood cholesterol in adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.
3. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442–443.
4. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119: 812–819.
5. Garni AS, Witt BJ, Howard DE, Erwin PJ, Garni LA, Somers VK et al. Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 2007; 49: 403–414.
6. Grundy SM, Brewer B, Cleeman JI, Smith SC, Lenfant C, for the Conference Participants. Definition of metabolic syndrome: report of the National Heart Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.
7. Meigs J. Metabolic syndrome: in search of a clinical role. Diabetes Care 2004; 27: 2761–2763.
8. Kohli P, Greenland P. Role of the metabolic syndrome in risk assessment for coronary heart disease. JAMA 2006; 295: 819–821.
9. Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr 2006; 83: 1248–1251.
10. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European Association for the study of diabetes. The metabolic syndrome: time for a clinical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289–2304.
11. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676–2681.
12. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 385–390.
13. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke and type 2 diabetes. Arch Intern Med 2005; 165: 2644–2650.
14. Lawlor DA, Smith GD, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study. Diabetologia 2006; 49: 41–48.
15. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007; 28: 857–864.
16. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 1981; 283: 179–186.
17. Walker M, Shaper AG, Lennon L, Whincup PH. Twenty year follow-up of a cohort study based in general practices in 24 British towns. J Public Health Med 2000; 22: 479–485.
18. Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414–419.
19. Eberly LE, Stamler J, Neaton JD, for the Multiple Risk factor Intervention Trial Research Group. Relation of triglyceride levels, fasting and non-fasting, to fatal and non-fatal coronary heart disease. Arch Intern Med 2003; 163: 1077–1083.
20. Najarian RM, Sullivan LM, Kannel WB, Wilson PWF, D’Agostino RB, Wolf PA. Metabolic syndrome compared with type 2 diabetesmellitus as a risk factor for stroke. Arch Intern Med 2006; 166: 106–111.
21. Wilson PWF, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066–3072.
22. Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 100: 1245–1250.
23. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004; 173: 309–314.
24. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1238–1239.
25. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356–362.
26. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W et al., Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians. The Strong Heart Study. Diabetes Care 2003; 26: 861–867.
27. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004; 110: 1251–1257.
28. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.
29. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC et al., Bruneck Study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Prospective data from the Bruneck Study. Diabetes Care 2003; 26: 1251–1257.
30. Li C, Ford ES. Definition of the metabolic syndrome: what’s new and what predicts risk. Metabolic Syndrome and Related Disorders 2006; 4: 237–251.
31. Kannel WB. Coronary heart disease risk factors in the Elderly. Am J Geriatr Cardiol 2002; 11: 101–107.
32. Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) 2005; 29: 1–19.
33. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F et al., for the ILSAWorking Group. Metabolic syndrome, diabetes and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006; 61: 505–510.
34. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE et al., for the Health ABC Study. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006; 47: 1595–1602.